---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-001682"
form_type: "8-K"
ticker: "EVFM"
cik: "0001618835"
company_name: "Evofem Biosciences, Inc."
filed_at: "2025-01-10T23:59:59+00:00"
generated_at: "2026-05-28T05:04:31.167558+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Evofem receives OTCQB delisting notice for trading below $0.01 for 30 days; 90-day cure period until April 6, 2025

## Summary
- Received OTC notice on Jan 6, 2025: closing bid price below $0.01 for 30 consecutive days violates Minimum Bid Price Requirement.
- Has 90-day compliance period until April 6, 2025 to regain compliance by having bid price >= $0.01 for 10 consecutive trading days.
- Failure to regain compliance by April 6, 2025 will result in removal of common stock from OTCQB.
- Company says it will monitor bid price and consider available options to resolve deficiency.

## SEC filing metadata
- accession: 0001493152-25-001682
- form_type: 8-K
- ticker: EVFM
- cik: 0001618835
- company_name: Evofem Biosciences, Inc.
- filed_at: 2025-01-10T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1618835/000149315225001682/0001493152-25-001682-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1618835/000149315225001682/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-001682
- JSON: https://secwatch.observer/filing/0001493152-25-001682.json
- Plain text: https://secwatch.observer/filing/0001493152-25-001682.txt

## Key facts
- Listing & Compliance Notices
  Evofem Biosciences, Inc. received a otc deficiency notice notice regarding minimum bid price.
  - Exchange: otc
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  source text: January 6, 2025, Evofem Biosciences, Inc. (the “Company”) received a written notice (the “OTC Notice”) from the OTC Markets Group (“OTC”) notifying the Company that, because the closing bid price for the Company’s common
  evidence_url: https://www.sec.gov/Archives/edgar/data/1618835/000149315225001682/0001493152-25-001682-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.